IBM Q2 2026 earnings: why the outlook fell to 4–5% growth
IBM's final second-quarter figures changed very little from the selected results it released eight days earlier. Revenue was US$17.162bn, Software grew 5.1%, Consulting grew 0.2% and Infrastructure fell 7.4%. Operating earnings per share remained US$2.93.
Our 14 July preliminary analysis identified the closing of delayed Software deals, the final segment mix, cash generation and any change to annual guidance as the evidence that would separate a timing problem from a weaker growth path. The completed report answered some of those questions.
The annual outlook did change. IBM lowered expected 2026 constant-currency revenue growth from more than 5% to 4–5%. Management said several Software deals that slipped out of June have since closed, but it made 4% growth the base case if recent customer-spending patterns persist. The final report therefore answered one timing question while leaving a larger one open: how much of the Software slowdown was delayed business, and how much reflects a weaker growth path?
The final result barely moved from the preliminary release
IBM's 22 July Form 8-K supplied the completed second-quarter release. The exact US$17.162bn revenue figure rounds to the US$17.200bn IBM disclosed on 14 July. The final segment growth rates also round to the preliminary figures: Software at 5.1%, Consulting at 0.2% and Infrastructure at negative 7.4%. This confirms the rounded figures examined in our preliminary-results article.
The final income statement reported US$2.165bn of GAAP net income and diluted GAAP earnings per share of US$2.27. IBM's operating non-GAAP earnings per share was US$2.93, unchanged from the preliminary figure. The final release therefore did not reveal a second material revision to the quarter itself.
The material new information was the annual outlook. IBM reduced expected full-year constant-currency revenue growth to 4–5%, down from the more-than-5% baseline it gave in April.
Total revenue
Q2 2026- Preliminary
- US$17.200bn · +1%
- Final
- US$17.162bn · +1.1%
- Change
- Exact result supplied
Operating EPS
IBM non-GAAP- Preliminary
- US$2.93
- Final
- US$2.93
- Change
- No change
FY2026 revenue outlook
Constant currency- April baseline
- More than 5%
- Final Q2 update
- 4–5%
- Change
- Outlook reduced
The preliminary values were rounded and the final figures are exact to the level IBM reported. Operating earnings per share is IBM's non-GAAP measure. The outlook comparison uses IBM's April baseline and the guidance issued with the final result.
Why IBM still cut the annual outlook
IBM's prepared remarks give the most useful explanation. Management said tens of large Software deals missed their expected second-quarter closing dates and that several had already closed in the first weeks of the third quarter. That is evidence that some revenue moved between periods rather than disappeared.
It was not enough for IBM to retain the old revenue range. The company reduced expected full-year constant-currency revenue growth to 4–5% and described 4% as its base case. The low end assumes the recent spending environment continues. The high end assumes a more typical rate of pipeline conversion during the second half.
IBM also reduced expected full-year Software growth to 6–8%. It now expects Infrastructure to grow by a low-single-digit percentage and Consulting to accelerate to low-to-mid-single-digit growth. The new range acknowledges that early third-quarter deal closures help, but do not fully restore the trajectory IBM expected in April.
Software was a mix problem, not a single result
Software generated US$7.761bn of revenue and grew 5.1%, but the components moved in different directions. Red Hat grew 11%, Data grew 19% and Automation grew 4%. Transaction Processing fell 8%. At constant currency, the respective rates were 11%, 18%, 3% and negative 9%.
IBM said about 80% of annual Software revenue is recurring. Software annual recurring revenue, or ARR, reached US$24.600bn and grew 8%. The remaining transactional portion fell by a high-single-digit percentage during the quarter. That split helps explain how a business with a large recurring base can still miss a quarterly growth plan when a relatively small number of large transactions move.
The acquisition contribution matters too. IBM said reported Software grew 5% while organic performance was flat. HashiCorp produced record bookings and IBM said Confluent remained on track, but those comments do not quantify revenue or prove that the acquired growth will offset weakness elsewhere. The next test is whether organic Software growth improves while the acquisitions are integrated.
The rest of IBM moved in different directions
The final release shows that weak revenue growth did not produce uniformly weaker segment margins. Software and Consulting margins expanded, while Infrastructure's margin contracted.
Software
Software- Revenue
- US$7.761bn
- YoY growth
- +5.1%
- Segment profit margin
- 32.2% · +1.1pts
Consulting
Consulting- Revenue
- US$5.327bn
- YoY growth
- +0.2%
- Segment profit margin
- 12.1% · +1.5pts
Infrastructure
Infrastructure- Revenue
- US$3.835bn
- YoY growth
- -7.4%
- Segment profit margin
- 21.8% · -1.5pts
The table uses IBM's final segment data. Margin changes are year-on-year percentage-point movements.
Infrastructure contained another sharp split. IBM Z revenue fell 42%, but Distributed Infrastructure grew 37% and ended the quarter with about US$500.000m of backlog. IBM said the z17 programme was still running at nearly 130% of the comparable z16 programme, so the quarterly IBM Z decline does not mean the installed programme stopped. It does mean recognised revenue was much weaker than the programme statistic alone suggests.
Consulting revenue was nearly flat, while signings grew 6%. Generative artificial intelligence, or GenAI, represented about half of signings and more than 30% of backlog. Signings and backlog can support future revenue, but the practical evidence is conversion. The next quarters need to show that the contracted work becomes reported Consulting growth.
Cash held up, but acquisitions reshaped the balance sheet
IBM generated US$7.766bn of operating cash flow in the first half, up from US$6.071bn a year earlier. Its company-defined free cash flow was US$4.760bn, almost flat with US$4.808bn in the first half of 2025. For the second quarter alone, free cash flow fell by US$305.000m to US$2.540bn.
The difference between operating cash flow and IBM's free-cash-flow measure matters. IBM removes the change in IBM Financing receivables and then deducts net capital expenditure. In the first half, US$7.766bn of operating cash flow, less US$2.264bn from the financing-receivables adjustment and US$743.000m of net capital expenditure, produced the reported US$4.760bn after rounding.
IBM invested US$10.480bn in acquisitions during the first half. Cash and cash equivalents fell from US$13.587bn at the end of 2025 to US$7.172bn at 30 June, while total debt was about US$62.000bn, including US$13.000bn attributed to IBM Financing. Goodwill and intangible assets also increased. The balance sheet now carries more of the acquisition strategy, so future reporting needs to show both integration progress and cash generation.
What the revised 2026 path now requires
IBM reported US$67.535bn of revenue in 2025 and US$33.079bn in the first half of 2026. The comparison translates several annual outcomes into the second-half revenue required.
Finish above FY2025
Reported-dollar illustration- FY2026 revenue
- More than US$67.535bn
- Required H2 revenue
- More than US$34.456bn
- H2 versus H1
- More than +4.2%
4% annual growth
Reported-dollar illustration- FY2026 revenue
- US$70.236bn
- Required H2 revenue
- US$37.157bn
- H2 versus H1
- +12.3%
5% annual growth
Reported-dollar illustration- FY2026 revenue
- US$70.912bn
- Required H2 revenue
- US$37.833bn
- H2 versus H1
- +14.4%
IBM's formal guidance is a constant-currency measure. IBM expects foreign exchange to be roughly neutral to full-year growth at current rates, but these are mechanical reported-dollar illustrations, not forecasts or a restatement of guidance.
IBM's 2025 reported revenue growth was 8%, or 6% at constant currency. Matching the prior year's reported 8% pace would require about US$72.938bn of 2026 revenue and US$39.859bn in the second half, 20.5% above the first half. That remains a historical comparison, not the target IBM now guides toward.
Cash flow sets a separate requirement. IBM retained its expectation for company-defined free cash flow to grow by about US$1.000bn from the US$14.734bn generated in 2025. That implies about US$15.734bn for 2026 and leaves approximately US$10.974bn for the second half after the US$4.760bn first-half result. IBM's cash generation is seasonal, so the calculation makes the remaining requirement visible without treating it as a quarterly run rate.
What remains uncertain
The first uncertainty is deal conversion. Several slipped Software transactions closed early in the third quarter, but IBM did not disclose their value or say that every delayed deal closed. The next result needs to show whether Software growth recovers within the new 6–8% annual range.
The second is organic growth. Acquisitions supported reported Software growth while organic performance was flat. HashiCorp and Confluent can add products, customers and recurring revenue, but the reported figures do not yet show the long-term growth or return from the US$10.480bn invested in acquisitions during the first half.
The third is cash delivery. IBM retained its free-cash-flow expectation despite flat first-half performance and a large second-half requirement. Revenue mix, working capital, taxes, interest and integration costs can all affect the path.
The metrics to monitor next
IBM expects third-quarter constant-currency revenue growth to be consistent with the new 4–5% full-year range. At current rates, currency is expected to reduce third-quarter reported growth by about 1.5 percentage points. Management also expects the third-quarter operating pre-tax margin to be similar to the second quarter's 19.2%.
Inside Software, watch organic growth, Transaction Processing, Red Hat, Data, Automation, ARR and the conversion of delayed transactions. Inside Infrastructure, compare IBM Z recognised revenue with the z17 programme measure and track the US$500.000m Distributed Infrastructure backlog. For Consulting, compare signings and GenAI backlog with reported revenue.
At company level, monitor the 4–5% constant-currency revenue range, the 100-basis-point full-year operating pre-tax margin expansion target, the US$10.974bn mechanical second-half free-cash-flow requirement, acquisition integration and the cash-and-debt position. Those measures can show whether the second quarter was mainly a timing disruption or the start of a slower operating path.
Sources
11 references- IBM 22 July 2026 Form 8-Ksec.gov
- IBM final Q2 release, Exhibit 99.1sec.gov
- IBM non-GAAP measures, Exhibit 99.2sec.gov
- IBM Q2 2026 prepared remarksibm.com
- IBM Q2 2026 earnings eventibm.com
- IBM 14 July preliminary investor lettersec.gov
- IBM first-quarter 2026 resultsnewsroom.ibm.com
- IBM full-year 2025 resultsnewsroom.ibm.com
- Reuters reporting on IBM's outlook reductionstreetinsider.com
- IBM historical market datafinancialcontent.com
- Open IBM in Helmbeamhelmbeam.com
Frequently asked questions
Did IBM's final Q2 2026 results differ from the preliminary figures?
Only slightly. Final revenue was US$17.162bn, which rounds to the preliminary US$17.200bn. The final segment growth rates and US$2.93 operating earnings per share also remained close to or matched the early disclosure. The material new information was the reduction in full-year constant-currency revenue growth to 4–5%.
Why did IBM cut its outlook if delayed Software deals have already closed?
IBM said several delayed transactions closed early in the third quarter, but reduced the annual range because recent customer-spending patterns and slower pipeline conversion still weaken the full-year path. The 4% base case assumes those conditions persist; the 5% case assumes more typical conversion during the second half.
Is IBM's business broken after the Q2 slowdown?
The results do not support that simple conclusion. Software and Consulting margins expanded, recurring Software revenue grew, Distributed Infrastructure rose 37% and several delayed deals closed. The concern is narrower but material: organic Software was flat, Transaction Processing and IBM Z fell, annual revenue guidance was reduced and the second half carries a large cash-flow requirement. Later results need to show which side persists.
Helmbeam is a research and analysis tool operated by Scydex Ltd. Scydex Ltd is not authorised or regulated by the Financial Conduct Authority. Helmbeam does not provide investment advice, recommendations, or solicitations to buy or sell securities. All data is for informational purposes only. Past performance of any signal, cohort, or classification does not guarantee future results. All investing involves risk, including loss of principal. Always conduct your own research and consult a qualified financial adviser before making investment decisions.
Where Helmbeam fits in the research process
Helmbeam helps readers track whether reported changes in revenue, margins, cash generation and valuation develop into a structural setup. For IBM, the next evidence is the conversion of delayed Software deals, organic Software growth, segment mix and the remaining free-cash-flow requirement.
As at 23 July 2026, Helmbeam displayed IBM as IGNORE. In Helmbeam, IGNORE means no setup is active or forming for the ticker right now. It does not decide whether IBM's business is improving or weakening, and the live state can change as new evidence arrives.
For dated historical context, Helmbeam's last recorded IBM window began on 17 October 2008 with an adjusted structural gate of US$45.19. From that original gate to Helmbeam's latest available adjusted close, IBM's price change was +355.33% as at 23 July 2026. The latest close underlying that production calculation was US$205.77 on 22 July. This is a price-only comparison from Helmbeam's window-entry reference, before trading costs, not an executed, annualised or portfolio return, and it does not override the current IGNORE state.
Every stock is a research opportunity, but not every stock has an active setup. Open IBM in Helmbeam to check its live state, place the dated window history beside the final Q2 evidence and see whether later results change the structure. Verify material company figures against the primary sources above.
Helmbeam is available as a free download on iOS and Android.
